drugset / Trial / NCT00002773

Vaccine Therapy, Chemotherapy, and GM-CSF in Treating Patients With Advanced Pancreatic Cancer

NCT00002773

Treatment

Summary

RATIONALE: Vaccines made from donated tumor cells treated with interferon alfa may make the body build an immune response to and kill pancreatic tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Colony-stimulating factors may help a person's immune system recover from the side effects of chemotherapy. Combining these treatments may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining vaccine therapy using donated tumor cells treated with interferon alfa and radiation therapy and cyclophosphamide plus GM-CSF in treating patients with advanced pancreatic cancer.

Timeline

Start
1996-05
Primary completion
Completion
2004-04

Drugs

EvaluationDrugModalityDoseRoute
Subject allogeneic tumor cell vaccine Vaccine Other
Background Cyclophosphamide Other / unclassified Intravenous
Background interferon alfa-2b Protein / enzyme biologic
Background sargramostim Protein / enzyme biologic Subcutaneous